Prime Medicine, Inc.PRMENASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank17
Studio
Year-over-Year Change

Return on equity

Latest
-166.41%
↓ 57% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-106.15%
Historical baseline
PeriodValueYoY Change
2025-166.41%-30.1%
2024-127.90%+14.1%
2023-148.89%-286.6%
2022-38.52%+44.2%
2021-69.03%-577.6%
2020-10.19%+94.4%
2019-182.07%-